| KEGG |
NOD-like receptor signaling pathway |
0,01 |
up |
| KEGG |
Small cell lung cancer |
0,03 |
up |
| KEGG |
Vitamin B6 metabolism |
0,05 |
up |
| KEGG |
p53 signaling pathway |
0,05 |
up |
| KEGG |
PPAR signaling pathway |
0,05 |
up |
| Metacore |
Immune response_IL-17 signaling pathways |
0 |
up |
| Metacore |
Immune response_Alternative complement pathway |
0 |
up |
| Metacore |
Cytokine production by Th17 cells in CF |
0,00021 |
up |
| Metacore |
Cell cycle_Regulation of G1/S transition (part 1) |
0,00023 |
up |
| Metacore |
Cell cycle_Regulation of G1/S transition (part 2) |
0,0006 |
up |
| Metacore |
Development_TGF-beta-dependent induction of EMT via MAPK |
0,0007 |
up |
| Metacore |
Cytokine production by Th17 cells in CF (Mouse model) |
0,00085 |
up |
| Metacore |
Cell cycle_Nucleocytoplasmic transport of CDK/Cyclins |
0,00122 |
up |
| Metacore |
Development_TGF-beta-dependent induction of EMT via SMADs |
0,00256 |
up |
| Metacore |
Immune response_Th17-derived cytokines |
0,00262 |
up |
| Metacore |
Development_PEDF signaling |
0,00361 |
up |
| Metacore |
Cytoskeleton_Regulation of cytoskeleton rearrangement |
0,00381 |
up |
| KEGG |
Focal adhesion |
0,001 |
down |
| KEGG |
Notch signaling pathway |
0,002 |
down |
| KEGG |
Prion diseases |
0,003 |
down |
| KEGG |
ECM-receptor interaction |
0,007 |
down |
| KEGG |
Lysosome |
0,01 |
down |
| KEGG |
Gap junction |
0,011 |
down |
| KEGG |
Axon guidance |
0,012 |
down |
| KEGG |
Inositol phosphate metabolism |
0,015 |
down |
| KEGG |
Bladder cancer |
0,03 |
down |
| KEGG |
Tight junction |
0,033 |
down |
| KEGG |
Neurotrophin signaling pathway |
0,034 |
down |
| KEGG |
Insulin signaling pathway |
0,035 |
down |
| KEGG |
Valine, leucine and isoleucine degradation |
0,038 |
down |
| KEGG |
Chronic myeloid leukemia |
0,044 |
down |
| KEGG |
Endocytosis |
0,044 |
down |
| KEGG |
N-Glycan biosynthesis |
0,047 |
down |
| KEGG |
Adherens junction |
0,051 |
down |
| Metacore |
Cell adhesion_Amyloid proteins |
0 |
down |
| Metacore |
Immune response_Histamine signaling in dendritic cells |
0,00001 |
down |
| Metacore |
Signal transduction_cAMP signaling |
0,00001 |
down |
| Metacore |
Development_S1P2 and S1P3 receptors in cell proliferation and differentiation |
0,00001 |
down |
| Metacore |
Development_Blood vessel morphogenesis |
0,00001 |
down |
| Metacore |
Development_Notch Signaling Pathway |
0,00002 |
down |
| Metacore |
Development_A2A receptor signaling |
0,00002 |
down |
| Metacore |
Blood coagulation_GPCRs in platelet aggregation |
0,00002 |
down |
| Metacore |
Cell adhesion_Platelet aggregation |
0,00002 |
down |
| Metacore |
Cytoskeleton_Actin filaments |
0,00002 |
down |
| Metacore |
Development_Neurogenesis_Axonal guidance |
0,00006 |
down |
| Metacore |
Development_A2B receptor: action via G-protein alpha s |
0,00008 |
down |
| Metacore |
Signal transduction_Activation of PKC via G-Protein coupled receptor |
0,00012 |
down |
| Metacore |
Transcription_CREB pathway |
0,00013 |
down |
| Metacore |
PGE2 pathways in cancer |
0,00018 |
down |
| Metacore |
Signal Transduction_Cholecystokinin signaling |
0,00052 |
down |
| Metacore |
Cytoskeleton_Regulation of cytoskeleton rearrangement |
0,00105 |
down |
| Metacore |
Muscle contraction_Nitric oxide signaling in the cardiovascular system |
0,00197 |
down |
| Metacore |
Development_Hedgehog signaling |
0,00287 |
down |
| Metacore |
Cell adhesion_Leucocytechemotaxis |
0,00747 |
down |
